Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced       Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 12pp  PDF  |   File History  |   Other choices   
  Tools:  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
 
 Email this to a friend  Email this to a friend 
       
Title: EP0219076A2: Sustained release composition[German][French]
[ Derwent Title ]


Country:
Kind:
EP European Patent Office (EPO)
A2 APPLICATION PUBLISHED WITHOUT SEARCH REPORT i (See also: EP0219076A3, EP0219076B1 )

View Images High
Resolution

 Low
 Resolution

 
12 pages

 
Inventor: Fujioka, Keiji;
Sato, Shigeji;
Tamura, Nobuhiko;
Takada, Yoshihiro;

Assignee: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
 News, Profiles, Stocks and More about this company

Published / Filed: 1987-04-22 / 1986-10-10

Application Number: EP1986000114067

IPC Code: Advanced: A61K 9/20; A61K 9/22;
IPC-7: A61K 9/22; A61K 37/02; A61K 37/36;

ECLA Code: A61K9/20H6D2;

Priority Number:
1985-10-11  JP1985000227590
1986-09-19  JP1986000223250
1986-09-19  JP1986000223251

Abstract:     A sustained release composition applicable for human beings and mammals which comprises (a) a silicone elastomer and (b) a pharmaceutical substance optionally with (c) albumin. When the pharmaceutical substance is of high molecular weight and can exert its pharmaceutical effect in a trace amount, its continuous release over a long period is attained by application of this invention.

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

Designated Country: AT BE CH DE ES FR GB IT LI NL SE

Family: Show 15 known family members

First Claim:
Show all claims
    1. A sustained release composition which comprises a silicone elastomer and a high molecular weight pharmaceutical substance contained therein.

Description
Expand description

    The present invention relates to a sustained release composition. More particularly, it relates to a long-term sustained release composition to be applied to mammals or human beings which comprises a pharmaceutical (i.e. pharmacologically or physiologically active) substance, particularly of high molecular weight, as an active ingredient and can maintain an effective level of said pharmaceutical substance over a long period of time.
+ Example 1
+ Example 2
+ Example 3
+ Example 4
+ Test 1
+ Test 2
+ Example 5
+ Example 6
+ Example 7
+ Example 8
+ Test 3
+ Test 4
+ Test 5
+ Test 6

       
Forward References: Go to Result Set: Forward references (6)
Buy
PDF
Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 30pp US6262127  2001-07-17 Acemoglu; Murat  Novartis AG Polymeric matrices and their uses in pharmaceutical compositions
Buy PDF- 28pp US6083521  2000-07-04 Acemoglu; Murat  Novartis AG Polymeric matrices and their uses in pharmaceutical compositions
Buy PDF- 3pp US6028062  2000-02-22 Upmeyer; Hans-Jurgen   Use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (Hp) associated syndromes and infectious diseases
Buy PDF- 3pp US5834004  1998-11-10 Upmeyer; Hans-Jurgen   Enteral composition comprising dimethicone and a photosensitizer and a method of delivery
Buy PDF- 13pp US5028430  1991-07-02 Sanders; Lynda M.  Syntex (U.S.A.) Inc. Delivery systems for the controlled administration of LHRH analogs
Buy PDF- 6pp US4889722  1989-12-26 Sheffield; Warren D.  Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
       
Other Abstract Info: None

Inquire Regarding Licensing

Powered by Verity


Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

Thomson Reuters Copyright © 1997-2013 Thomson Reuters 
Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help